PROGRAM COMMITTEE

CHAIRS:

Isao Kamae MD, DrPH, Professor of Health Informatics and Science, Research Center for Urban Safety and Security, and Graduate School of Medicine, Kobe University, Kobe, Japan

Naoki Ikegami MD, MA, Professor and Chair, Department Of Health Policy & Management, School of Medicine, Keio University, Tokyo, Japan

Shuzo Nishimura PhD, Professor, Faculty of Economics, Kyoto University, Kyoto, Japan

PROGRAM COMMITTEE MEMBERS:

JAPANESE MEMBERS:
EXECUTIVE PROGRAM COMMITTEE:

Toshihiko Hasegawa MD, Director of Health Policy Science, National Institute of Public Health, Department of Policy Sciences, Saitama-ken, Japan

Yuji Inoue MD, Professor and Chairman, Yamaguchi University, Department of Medical Informatics and Decision Sciences, Yamaguchi University School of Medicine, Yamaguchi, Japan

Shunzo Koizumi MD, PhD, Professor, Division of General Medicine, Saga Medical School Hospital, Saga, Japan

Masayoshi Murakami MD, Director of Clinical Research Coordination, Foundation of Biomedical Research and Innovation, Kobe, Japan

Koichi Nobutomo MD, DMSc, Professor of Healthcare Systems, Graduate School of Medicine, Kyushu University, Fukuoka, Japan

Katsuhiko Okumura PhD, Professor and Director, Department of Hospital Pharmacy, Kobe University School of Medicine, Kobe, Japan

Tsunetaro Sakurai MD, Professor and Director of Medical Informatics, Hokkaido University, Medical Hospital, Department of Medical Information, Sappro, Japan

Makoto Shiragami PhD, Professor, Nihon University, College of Pharmacy, Social and Administrative Pharmacy Science, Chiba, Japan

Kiichiro Tsutani MD, Professor of Pharmacoeconomics, University of Tokyo, Graduate School of Pharmaceutical Sciences, Tokyo, Japan

LOCAL PROGRAM COMMITTEE:

Takashi Fukuda PhD, Associate Professor, Department of Pharmacoeconomics, University of Tokyo, Tokyo, Japan

Shunya Ikeda MD, MS, DMSc, Assistant Professor, Department of Health Policy & Management, Keio University, School of Medicine, Tokyo, Japan

Makoto Kobayashi ME, Manager, CRECON Research & Consulting Inc, Tokyo, Japan
Yasushi Ohkusa PhD, Associate Professor, Institute of Social and Economic Research, Osaka University, Osaka Japan

Hiroyuki Sakamaki, Chief Researcher, Institute for Health Economics and Policy, Research Department, Tokyo, Japan

Takuro Shimbo MD, General Medicine and Clinical Epidemiology, School of Medicine, Kyoto University, Kyoto, Japan

Shinichiro Yanagisawa MCSc, Research Associate, Health Informatics and Sciences, Kobe University, Kobe, Japan

CHINESE MEMBERS:

Kenneth KC Lee PhD, Associate Professor & Head, Division of Pharmacy Practice, Pharmacy Department, The Chinese University of Hong Kong, Shatin, Hong Kong

Zhiqiang Guan MD, Head of Health Insurance Research Department, National Institute of Social Insurance, Ministry of Labor and Social Security, Beijing, China

KOREAN MEMBER:
Bong-min Yang PhD, Seoul National University, School of Public Health, Seoul, Korea

SINGAPORE MEMBER:
Shu Chuen Li MBA, PhD, Assistant Professor, Department of Pharmacy, National University of Singapore, Singapore, Singapore

THAILAND MEMBER:
Nathorn Chaiyakunapruk PharmD, PhD, Instructor, Naresuan University, School of Pharmacy, Pitsanuloak, Thailand

TAIWAN MEMBER:
Yen-Huei (Tony)Tarn PhD, Associate Professor, School of Pharmacy, National Defense Medical Center, Taipei,Taiwan

PROGRAM ADVISORY COMMITTEE CHAIRS

Jim Doherty PhD

Yoshihiro Kanno, Department Manager, Pharmacoeconomics, GlaxoSmithKline, Tokyo, Japan

Dear Colleagues,

On behalf of the Program Planning Committee, we are very pleased to welcome you to Kobe, and to the First Asia-Pacific Conference of the International Society for Pharmacoeconomics and Outcomes Research. As theme, we have chosen to focus on the role of pharmacoeconomics and outcomes research in Asia-Pacific countries.

The highlights in the program are the two plenary sessions. The first focuses on the role of pharmacoeconomics and outcomes research in health care decisions, and the second is an international comparison of health care reimbursement systems and the use of pharmacoeconomics in the reimbursement process. In addition, we are very excited to have two special sessions one on the Japanese health care system: structure, dynamics, lessons, and the other on data sources for pharmacoepidemiology and pharmacoeconomics studies in Asia-Pacific countries. Furthermore, we were impressed by the quality of the submitted contributions and are confident that presentations and debate on research projects will be of high quality.

We are extremely grateful to the members of the planning committee who have substantial time and energy in planning this conference. Finally, we would like to acknowledge the efforts of Marilyn Dix Smith, the Executive Director of ISPOR, and her highly skilled staff for their dedication to the success of this conference.

We hope that your stay is pleasant and that you have time to explore and enjoy the cultural treasures of Kobe.

Sincerely,

Isao Kamae MD, DrPH, Kobe University, Kobe, Japan (pictured top)
Naoki Ikegami MD, MA, Keio University, Tokyo, Japan (pictured middle)
Shuzo Nishimura PhD, Kyoto University, Kyoto, Japan

Generously supported by the